-
281
Contribution of Microglia-Mediated Neuroinflammation to Retinal Degenerative Diseases
Published 2015-01-01“…One common feature of retinal degenerative diseases and brain neurodegenerative diseases is chronic neuroinflammation. There is growing evidence that retinal microglia, as in the brain, become activated in the course of retinal degenerative diseases, having a pivotal role in the initiation and propagation of the neurodegenerative process. …”
Get full text
Article -
282
NREM and REM sleep parasomnias: clinical cases and literature review
Published 2021-06-01“…NREM parasomnias are often benign, self-limited, or resolved with non-pharmacological treatment, while REM sleep behaviour disorder (example of REM parasomnias) is much more likely to occur in adult age and is associated with neurodegenerative diseases. There are 3 types of parasomnias associated with REM sleep: REM sleep behaviour disorder (RBD), isolated sleep paralysis, and nightmare disorder. …”
Get full text
Article -
283
Neuroplasticity in Alzheimer's disease: a therapeutic alternative at the molecular level
Published 2020-08-01“…The neuroplasticity mechanisms of the organism form the basis of dissimilar therapies that seek to potentiate such effects to achieve relative improvement in a large number of neurodegenerative diseases. Included within this high number of conditions, Alzheimer's disease stands out, due to its direct relationship with the alarming figures of population aging in Cuba and the world. …”
Get full text
Article -
284
Advances in Gene Therapy for Neurologic Disorders: An Overview
Published 2025-02-01“…This review addresses gene therapy developments and obstacles for neurodegenerative diseases and discusses emerging strategies, goals, and prospects.…”
Get full text
Article -
285
Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models
Published 2016-01-01“…Moreover, elucidating epigenetic regulation using patient-specific iPSC-derived neural models is expected to have a great impact to unravel the pathophysiology of neurodegenerative diseases and to hopefully expand future therapeutic possibilities. …”
Get full text
Article -
286
-
287
Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy
Published 2014-01-01“…Tissues or organs derived from hPS cells could be the best solution to cure many different human diseases, especially those who do not respond to standard medication or drugs, such as neurodegenerative diseases, heart failure, or diabetes. The origin of hPS is critical and the idea of creating a bank of well-characterized hPS cells has emerged, like the one that already exists for cord blood. …”
Get full text
Article -
288
Widespread Striatal Delivery of GDNF from Encapsulated Cells Prevents the Anatomical and Functional Consequences of Excitotoxicity
Published 2019-01-01“…Because GDNF has been effective in animal models of Parkinson’s disease, stroke, epilepsy, and Huntington’s disease, among other debilitating neurodegenerative diseases, encapsulated cell-based delivery of GDNF might represent one innovative means of slowing the neural degeneration seen in a myriad of currently untreatable neurological diseases.…”
Get full text
Article -
289
Essential Oils May Lead α-Synuclein towards Toxic Fibrils Formation
Published 2016-01-01“…It is believed that exposure to the factors which promote fibrillation may induce and progress such neurodegenerative diseases (NDs). Herein, the effects of some wildly used essential oils including Myrtus communis (M. communis) on α-Syn fibrillation were examined. …”
Get full text
Article -
290
Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets
Published 2025-01-01“…Disruption of this balance can lead to pathological conditions, including neurodegenerative diseases, cancer, and viral infections. Consequently, biomolecular condensates have emerged as promising therapeutic targets, with the potential to offer novel approaches to disease treatment. …”
Get full text
Article -
291
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
Published 2011-01-01“…In the last decade, PPAR-γ agonists have received increasing attention for their neuroprotective properties displayed in a variety of neurodegenerative diseases, including Parkinson's disease (PD), likely related to the anti-infammatory activity of these compounds. …”
Get full text
Article -
292
Insights into the Allosteric Regulation of Human Hsp90 Revealed by NMR Spectroscopy
Published 2024-12-01“…Errors in the process of the chaperone cycle can lead to diseases such as cancer and neurodegenerative diseases. Therefore, the activity of Hsp90 must be carefully regulated. …”
Get full text
Article -
293
New Insights into Chemical Profiles and Health-Promoting Effects of Edible Mushroom <i>Dictyophora indusiate</i> (Vent ex. Pers.) Fischer: A Review
Published 2025-01-01“…DIP shows neuroprotective effects by reducing oxidative damage, improving mitochondrial function, and regulating apoptosis, making them beneficial for neurodegenerative diseases. They also activate immune responses through TLR4 and NF-κB pathways. …”
Get full text
Article -
294
Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
Published 2016-01-01“…Several studies have demonstrated the therapeutic potential of applying microtubule- (MT-) stabilizing agents (MSAs) that cross the blood-brain barrier to promote axon regeneration and prevent axonal dystrophy in rodent models of spinal cord injury and neurodegenerative diseases. Paradoxically, administration of MSAs, which have been widely prescribed to treat malignancies, is well known to cause debilitating peripheral neuropathy and axon degeneration. …”
Get full text
Article -
295
Antioxidant and anti-inflammatory roles of tea polyphenols in inflammatory bowel diseases
Published 2022-05-01“…High intake of tea polyphenols has been described to prevent and/or attenuate a variety of chronic pathological conditions like cardiovascular diseases, neurodegenerative diseases, diabetes, and cancer. This review focuses on established antioxidant and anti-inflammatory properties of tea polyphenols and underlying mechanisms of their involvement in inflammatory bowel diseases (IBD). …”
Get full text
Article -
296
The Role of the Innate Immune System in Alzheimer’s Disease and Frontotemporal Lobar Degeneration: An Eye on Microglia
Published 2013-01-01“…In this framework, the purpose of this review is to give an overview of clinical features, genetics, and novel discoveries on biomolecular pathogenic mechanisms at the basis of these two neurodegenerative diseases and to outline current evidence regarding the role played by activated microglia in their pathogenesis.…”
Get full text
Article -
297
Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
Published 2010-01-01“…Accumulation of α-synuclein is observed in neurodegenerative diseases like Parkinson's disease and Multiple System Atrophy. …”
Get full text
Article -
298
Cognitive disorders: Potential astrocyte-based mechanism
Published 2025-01-01“…The contributing factors of cognitive disorders are numerous and diverse in nature, including organic diseases and other mental disorders. Neurodegenerative diseases are a common type of organic disease related to the pathology of neuronal death and disruption of glial cell balance, ultimately accompanied with cognitive impairment. …”
Get full text
Article -
299
Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease
Published 2024-12-01“…However, several compounds, administered parenterally and orally, are unable to reach the brain due to the presence of the blood-brain barrier (BBB) which prevents the passage of external substances, such as proteins, peptides, or phytocompounds, representing a limit to the development of treatment for neurodegenerative diseases, such as AD. The combination of nano vesicular systems, as colloidal systems, and nose to brain (NtB) delivery depicts a new nanotechnological strategy to overtake this limit and to develop new treatment approaches for brain diseases, including the use of natural molecules in combination therapy for AD. …”
Get full text
Article -
300
Patient-Specific Pluripotent Stem Cells in Neurological Diseases
Published 2011-01-01“…Patient-specific iPSC-based modeling of neurogenetic and neurodegenerative diseases is an emerging efficient tool for in vitro modeling to understand disease and to screen for genes and drugs that modify the disease process. …”
Get full text
Article